FDAnews
www.fdanews.com/articles/72069-exelixis-achieves-35-million-in-milestones-from-gsk

Exelixis Achieves $35 Million in Milestones From GSK

May 9, 2005

Exelixis, Inc. announced that it has achieved two milestones totaling $35 million under its collaboration agreement with GlaxoSmithKline (GSK). The first of these milestones, totaling $30 million, was achieved as a result of the submission of the investigational new drug (INDs) applications for XL880 in December 2004, and XL820 and XL844 in April 2005.

PR Newswire (http://www.prnewswire.com/cgi-bin/stories.pl?ACCT=104&STORY=/www/story/05-09-2005/0003589429&EDATE=)